Lung Cancer
Web Exclusives | August 23, 2021
Despite guideline recommendations, a retrospective study found inadequate biomarker testing rates to direct targeted therapy.
Web Exclusives | August 23, 2021
Researchers highlighted promising research into early-stage diagnostics and therapies for NSCLC harboring the KRAS G12C mutation discussed in a review article.
Web Exclusives | August 23, 2021
A recent study found that chronic pneumonitis is a rare complication of immune checkpoint inhibitor therapy in patients with NSCLC.
Web Exclusives | August 23, 2021
A retrospective analysis demonstrated a 10-point difference in receipt of NGS testing between white and black patients with NSCLC.
Web Exclusives | July 28, 2021
Recently released study results report similar chemo-immunotherapy outcomes in KRAS-mutant NSCLC subtypes and poor results in patients with concurrent STK11 and/or KEAP1 mutations.
Web Exclusives | July 28, 2021
A recently released retrospective study demonstrates that NSAID use in patients with NSCLC enhances immune checkpoint efficacy.
Web Exclusives | July 28, 2021
Subgroup analysis of CodeBreaK 100 trial results found that sotorasib achieved a response in pretreated patients with KRASG12C-mutated NSCLC subtypes.
Web Exclusives | July 28, 2021
Results from an incidental lung nodule program implemented in a community healthcare system demonstrates this program detects lung cancer in patients who are otherwise ineligible for LDCT screening.
Web Exclusives | June 23, 2021
Patients with advanced KRASG12C harboring NSCLC maintained quality of life and physical functioning with tolerable side effects while being treated with sotorasib.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512